Francesca Mordant

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.

Adam K Wheatley, Jennifer A Juno, Jing J Wang, Kevin J Selva, Arnold Reynaldi, Hyon-Xhi Tan, Wen Shi Lee, Kathleen M Wragg, Hannah G Kelly, Robyn Esterbauer, Samantha K Davis, Helen E Kent, Francesca L Mordant, Timothy E Schlub, David L Gordon, David S Khoury, Kanta Subbarao, Deborah Cromer, Tom P Gordon, Amy W Chung, et al.

Journal article  |  2021  |  Nature Communications

The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection and vaccine development. Here, we s..

Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort.

CR Bailie, L Franklin, S Nicholson, F Mordant, C Alpren, T Stewart, C Barnes, A Fox, J Druce, K Subbarao, M Catton, A van Diemen, SG Sullivan

Journal article  |  2021  |  Epidemiology and Infection

Much of our current understanding about novel coronavirus disease 2019 (COVID-19) comes from hospitalised patients. However, the s..

Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection

Jessie J-Y Chang, Daniel Rawlinson, Miranda Pitt, George Taiaroa, Josie Gleeson, Chenxi Zhou, Francesca Mordant, Ricardo De Paoli-Iseppi, Leon Caly, Damian FJ Purcell, Tim Stinear, Sarah Londrigan, Michael Clark, Deborah Williamson, Kanta Subbarao, Lachlan JM Coin

Journal article  |  2020

Summary SARS-CoV-2 uses subgenomic (sg)RNA to produce viral proteins for replication and immune evasion. We applied long-read RNA ..

Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19

Shidan Tosif, Melanie R Neeland, Philip Sutton, Paul V Licciardi, Sohinee Sarkar, Kevin J Selva, Anh Ha Do Lien, Celeste Donato, Zheng Quan Toh, Rachel Higgins, Carolien Van de Sandt, Melissa M Lemke, Christina Y Lee, Suzanne K Shoffner, Katie L Flanagan, Kelly B Arnold, Francesca L Mordant, Kim Mulholland, Julie Bines, Kate Dohle, et al.

Journal article  |  2020  |  Nature Communications

Compared to adults, children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have predominantly mild or asymptom..

Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting

Katherine Bond, Suellen Nicholson, Seok Ming Lim, Theo Karapanagiotidis, Eloise Williams, Douglas Johnson, Tuyet Hoang, Cheryll Sia, Damian Purcell, Francesca Mordant, Sharon R Lewin, Mike Catton, Kanta Subbarao, Benjamin P Howden, Deborah A Williamson

Journal article  |  2020  |  Journal of Infectious Diseases

BACKGROUND: Robust serological assays are essential for long-term control of the COVID-19 pandemic. Many recently released point-o..

Molecular clamp stabilised Spike protein for protection against SARS-CoV-2

Daniel Watterson, Danushka Wijesundara, Naphak Modhiran, Francesca Mordant, Zheyi Li, Michael Avumegah, Christopher McMillan, Julia Lackenby, Kate Guilfoyle, Geert van Amerongen, Koert Stittelaar, Stacey Cheung, Summa Bibby, Mallory Daleris, Kym Hoger, Marianne Gillard, Eve Radunz, Martina Jones, Karen Hughes, Ben Hughes, et al.

Journal article  |  2020

Efforts to develop and deploy effective vaccines against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continue at ..

Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience

Kanta Subbarao, Francesca Mordant, Rajeev Rudraraju

Journal article  |  2020  |  European Journal of Immunology

The COVID-19 pandemic caused by the zoonotic coronavirus, SARS-CoV-2 has swept the world in 5 months. A proportion of cases develo..

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

Jennifer A Juno, Hyon-Xhi Tan, Wen Shi Lee, Arnold Reynaldi, Hannah G Kelly, Kathleen Wragg, Robyn Esterbauer, Helen E Kent, C Jane Batten, Francesca L Mordant, Nicholas A Gherardin, Phillip Pymm, Melanie H Dietrich, Nichollas E Scott, Wai-Hong Tham, Dale Godfrey, Kanta Subbarao, Miles P Davenport, Stephen J Kent, Adam K Wheatley

Journal article  |  2020  |  Nature Medicine

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has dramatically expedited global vaccine development ef..

How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines

Rajeev Rudraraju, Francesca Mordant, Kanta Subbarao

Journal article  |  2019  |  The Journal of Infectious Diseases

Immune responses to SARS-CoV-2 in children of parents with symptomatic COVID-19

Shidan Tosif, Melanie Neeland, Philip Sutton, Paul Licciardi, Sohinee Sarkar, Kevin Selva, Lien Anh Ha Do, Celeste Donato, Zheng Quan Toh, Rachel Higgins, Carolien van de Sandt, Melissa Lemke, Christina Lee, Suzanne Shoffner, Katie Flanagan, Kelly Arnold, Francesca Mordant, Kim Mulholland, Julie Bines, Kate Dohle, et al.

Journal article

Abstract Compared to adults, children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have mild or asymp..